RadNet shares fall 1.95% intraday after DeepHealth subsidiary receives FDA clearance for TechLive™.

Radnet, Inc. declined 1.95% in intraday trading, with the company's subsidiary, DeepHealth, receiving FDA 510(k) clearance for TechLive™, a remote scanning solution. This news is generally positive for the company, as it enables centralized scanning and addresses radiology technologist shortages, potentially increasing operational efficiency and access to advanced procedures.